{"id":3362,"date":"2021-06-21T19:56:51","date_gmt":"2021-06-21T19:56:51","guid":{"rendered":"https:\/\/stuarttherapeutics.com\/?page_id=3362"},"modified":"2024-04-22T23:15:02","modified_gmt":"2024-04-22T23:15:02","slug":"news","status":"publish","type":"page","link":"https:\/\/stuarttherapeutics.com\/news\/","title":{"rendered":"News"},"content":{"rendered":"
<\/h6>\n
For Additional Media and Publications, click here.<\/a><\/h6>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
APRIL 19, 2024<\/span>Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2024<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div>
\"Arvo<\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"https:\/\/stuarttherapeutics.com\/wp-content\/uploads\/Stuart-Therapeutics-Don-LR-1.jpg\"<\/a><\/div>
<\/div><\/div><\/div><\/div>
FEB 01, 2024<\/span>Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div><\/div><\/div>
OCT 18, 2023<\/span>Stuart Therapeutics Announces Exclusive Worldwide License Agreement with Glaukos Corporation<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div>
\"Glaukos<\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"Radium<\/a><\/div>
<\/div><\/div><\/div><\/div>
JUL 12, 2023<\/span>Stuart Therapeutics Enters into Term Sheet with Radium Capital for the Financing of Research and Development Tax Credits<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div><\/div><\/div>
MAR 09, 2023<\/span>Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2023 Annual Meeting<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div>
\"ARVO<\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"ST<\/a><\/div>
<\/div><\/div><\/div><\/div>
JUL 22, 2022<\/span>Stuart Therapeutics Announces Important Additions to the Company's Intellectual Property Portfolio<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div><\/div><\/div>
JULY 18, 2022<\/span>Stuart Therapeutics Announces Successful Outcome from Type C Meeting with FDA<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div>
\"Stuart<\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"ST-100<\/a><\/div>
<\/div><\/div><\/div><\/div>
JAN 03, 2022<\/span>Stuart Therapeutics, Inc. Announces Successful Phase 2 Clinical Trial Results of its Novel Dry Eye Candidate ST-100<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div><\/div><\/div>
SEPTEMBER 8, 2021<\/span>Stuart Therapeutics, Inc. Announces Completion of Patient Enrollment in Phase 2 Clinical Trial for Dry Eye Disease<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div>
\"Phase<\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"Stuart<\/a><\/div>
<\/div><\/div><\/div><\/div>
MARCH 19, 2021<\/span>Stuart Therapeutics Completes its $11M Series A Round, led by InFocus Capital Partners, WARF & MiMo Capital<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div><\/div><\/div>
MARCH 19, 2021<\/span>Stuart Therapeutics Announces Receipt of Study May Proceed Letter from U.S. FDA for ST-100 Dry Eye Disease Phase 2 Clinical Trial<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div>
\"Fda<\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"https:\/\/stuarttherapeutics.com\/wp-content\/uploads\/2021\/07\/Blog-Advanse-LR.jpg\"<\/a><\/div>
<\/div><\/div><\/div><\/div>
NOVEMBER 13, 2020<\/span>Stuart Therapeutics Wins the AdvanSE Life Sciences Conference PitchRounds Competition<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div><\/div><\/div>
FEBRUARY 16, 2020<\/span>Stuart Therapeutics, Inc. Announces Presentation at ARVO 2020<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read more ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div>
\"https:\/\/stuarttherapeutics.com\/wp-content\/uploads\/2021\/07\/Arvo-Blog-LR.jpg\"<\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"Pro-Neural-Growth\"<\/a><\/div>
<\/div><\/div><\/div><\/div>
NOVEMBER 11, 2019<\/span>Stuart Therapeutics, Inc. Announces Pro-Neuronal Growth Results Using PolyColTM Collagen Mimetic Peptides<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div><\/div><\/div>
JUNE 12, 2019<\/span>Stuart Therapeutics, Inc. Announces a Strategic Partnership with Ora, Inc.<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More > <\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div>
\"Stuart<\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
View Older Posts<\/a><\/span><\/span><\/h5><\/header>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"ST<\/a><\/div>
<\/div><\/div><\/div><\/div>
JUL 22, 2022<\/span>Stuart Therapeutics Announces Important Additions to the Company's Intellectual Property Portfolio<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":4316,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false},"_links":{"self":[{"href":"https:\/\/stuarttherapeutics.com\/wp-json\/wp\/v2\/pages\/3362"}],"collection":[{"href":"https:\/\/stuarttherapeutics.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stuarttherapeutics.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stuarttherapeutics.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stuarttherapeutics.com\/wp-json\/wp\/v2\/comments?post=3362"}],"version-history":[{"count":13,"href":"https:\/\/stuarttherapeutics.com\/wp-json\/wp\/v2\/pages\/3362\/revisions"}],"predecessor-version":[{"id":5081,"href":"https:\/\/stuarttherapeutics.com\/wp-json\/wp\/v2\/pages\/3362\/revisions\/5081"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stuarttherapeutics.com\/wp-json\/wp\/v2\/media\/4316"}],"wp:attachment":[{"href":"https:\/\/stuarttherapeutics.com\/wp-json\/wp\/v2\/media?parent=3362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}